FIELD: pharmaceuticals industry, in particular new method for production of alpha-1-antitrypsin and pharmaceutical product containing the same.
SUBSTANCE: alpha-1-antitrypsin is isolated from Cohn fraction IV-1 by solubilization. Then protein admixtures and eventual viral particles are removed by polyethylene glycol, target protein is precipitated with zinc salt, viral inactivation using solvent/detergent is carried out, product is fractionated using Q-sepharose, and non-active alpha-1-antitrypsin is removed with S-sepharose to produced target product. Said product represents concentrate of human serum active alpha-1-antitrypsin having purity more than 98 % and specific activity not less than 40 IU/mg in 0.15 M sodium chloride solution.
EFFECT: increased yield of high pure active alpha-1-antitrypsin.
4 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING HUMAN C-1 ESTERASE INHIBITOR AMD PRODUCT FOR USING IN MEDICINE | 2004 |
|
RU2256464C1 |
| METHOD OF ANTITROMBIN III MEDICATION PREPARATION OF HUMAN PLASMA | 2008 |
|
RU2357742C1 |
| METHOD FOR PREPARING HUMAN PLASMIN CONCENTRATE AND PRODUCT FOR ITS USING IN MEDICINE | 2004 |
|
RU2257224C1 |
| METHOD OF WHEAT CYSTEINE PROTEASE PROTEINS FAMILY (TRITICUM AESTIVUM) PRODUCING AND PREPARATION OF TRITIKAIE-ALPHA PROTEIN, OBTAINED USING SAID METHOD | 2015 |
|
RU2603054C2 |
| METHOD OF HUMAN BLOOD COAGULATION VIII FACTOR CONCENTRATE PRODUCTION AND RELATED PRODUCT | 2007 |
|
RU2326689C1 |
| METHOD FOR PRODUCTION OF ALPHA-FETOPROTEIN | 2006 |
|
RU2308286C1 |
| METHOD OF ALPHA-1-ANTITRYPSIN SOLUTION TREATMENT | 2004 |
|
RU2370500C2 |
| METHOD FOR MAKING HUMAN COAGULATION FACTOR IX CONCENTRATE | 2007 |
|
RU2353386C1 |
| METHOD TO PRODUCE MODIFIED FORM OF TRYPTOPHANYL-tRNA-SYNTHETASE | 2012 |
|
RU2495123C2 |
| HUMAN ENDOSTATIN PREPARATION AND METHOD FOR PRODUCTION THEREOF | 2004 |
|
RU2278688C1 |
